Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Narrative) (Details)

v3.22.2
Basis of Presentation (Narrative) (Details)
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 31, 2021
segment
Jun. 30, 2022
segment
Jun. 30, 2022
item
Basis of Presentation [Abstract]      
Number of FDA approved products | item     2
Number of operating segments | segment 2 1